StockWatch
·

PARAMOUNT COMMUNICATIONS LTD.-$ Q2 FY27 Results

PARACABLESQ2 FY27 Results
Filing
Result:Good· Market: Surged#Margin expansion#Broad based

Outlook: Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue560.405.9%30.9%
Total Income564.206.0%26.0%
Expenditure531.815.1%23.7%
PBT32.3922.0%82.0%
Net Profit24.2423.1%82.9%
OPM7.30%0.74pp5.85pp
NPM4.30%0.60pp1.34pp
EPS0.7415.6%72.1%
View full financials

Industrials core metric—revenue growth (+30.9% YoY) paired with EBITDA margin expansion to ~8% driven by operating leverage rather than one-offs—shows solid above-average quality, though rising finance costs and a non-like-for-like YoY base (divested subsidiary) keep it just shy of a standout.

PARAMOUNT COMMUNICATIONS LTD. · Q2 FY-2027 · THE VERDICT

31% Growth That Management Won't Bank On — The Margin Ramp Is the Real Story

Paramount delivered a 31% revenue pop and 83% PAT growth, but refused to raise full-year guidance. The call explains why — and reveals a company executing on margins rather than chasing top-line surprises.

02 Nov 2026 · 6 min read
Q2 Revenue

₹560.4 Cr

+31% YoY, +5.9% QoQ

Q2 PAT

₹24.2 Cr

+83% YoY, +23% QoQ

Operating Margin

7.3%

+67 bp QoQ, +170 bp YoY

FY27 Guidance (maintained)

15–20% growth

Not raised despite 31% Q2 print

On the surface, Paramount's Q2 looks like a blowout: 31% revenue growth and PAT up 83% year-on-year. But management did something unusual when it closed the earnings call — it didn't raise full-year guidance. Instead, it reaffirmed 15–20% FY27 growth, the same range from the prior quarter. That gap between the headline pop and the stubborn guidance is the story of the quarter.

Why the growth is outpacing guidance

The 31% revenue growth is real and sustainable, but it's not all organic. Q2 benefited from tariff normalization — the US IEPA tariffs were shut down by the US Supreme Court in February 2026, restoring customer confidence in export orders after months of uncertainty. Domestic business also held firm. But that tariff wind is a one-time tailwind, not a permanent shift in the FY27 run-rate. Management knows this, and it's being disciplined: the 15–20% FY27 guidance assumes the elevated growth base normalizes slightly as the year matures. That's credible execution discipline, not a miss.

The real story: margin recovery is on the glide path

The 7.3% operating margin in Q2 is the true signal of the quarter. This is a +67 basis point jump quarter-on-quarter from Q1's 6.6%, and it confirms management's guided trajectory towards 8% by Q4 FY27 (matching FY25's baseline). That glide path—6.6% (Q1) → 7.3% (Q2) → 8% (Q4)—is credible because it's supported by two real drivers: tariff normalization (allowing fixed costs to be spread over higher export volumes) and favorable metal pricing (aluminum showing softness, which is >75% of metal value in Paramount's mix).

Operating Margin trajectory, %
02.995.978.966.6Q1 FY277.3Q2 FY278Q4 FY27 target
Margin recovery is the real win. The trajectory from 6.6% to 8% is on track and credible.

The HTLS order book is impressive but unproven

Management announced a ₹200 crore HTLS (High Temperature Low Sag) order book during the call, a new-to-world product for Paramount. HTLS is a specialized conductor used in power transmission, and the national grid modernization plan projects ₹5 lakh crore in EHV transmission investment between 2027 and 2032 — a huge market. But here's the catch: Paramount reported zero revenue from HTLS in Q2. The orders are there, but execution is in the future. HTLS involves longer delivery cycles due to EPC (engineering, procurement, construction) work, and management guided that orders won't convert to revenue for several months. This is execution risk that will take time to validate. The order book is real, but scaling it will define the next two quarters.

Export guidance looks tight versus the run-rate

Management guided ₹700–800 crore in US exports for FY27. But H1 (first half) exports ran at ₹313 crore, which annualizes to roughly ₹626 crore—about 11% below the midpoint of guidance. Management capped exports at ~30% of revenue going forward, citing concentration risk and the desire to diversify back to Asia, Europe, and Oceania. That's a sensible risk-management call, but it also signals that the ₹700–800 crore guidance may require acceleration in H2 or a higher FY27 revenue base than the 15–20% guidance implies. It's a yellow flag, not a red one — the order book is strong at ₹731 crore — but watch this one.

The market has priced in deep skepticism

The stock is trading at ₹60.89, down 47.89% from its all-time high of ₹116.85. That's a jarring discount given that Paramount just delivered on its guided margin trajectory, has a ₹731 crore order book, and announced a ₹200 crore HTLS pipeline. The technical backdrop is mixed: RSI of 50 suggests neutral momentum, but volume is increasing, which hints at accumulation. Most tellingly, domestic institutional investors (DII) added 4 percentage points in Q2, while FII holdings remained flat at 0.45%. That's consistent with smart money quietly building positions ahead of the Narmadapuram ramp-up (partial commissioning expected Q1 FY28). The stock is not cheap relative to fair value, but the drawdown has created a window for patient capital.

Management's claims vs. what holds up

Verdict on key management assertions from the call

7.3% OPM in Q2 validates glide path to 8% by Q4

₹40.9 Cr operating profit / ₹560.4 Cr revenue = 7.3% ✓; margin expanded 67 bp QoQ and 170 bp YoY

Supported

31% revenue growth driven by domestic + export normalization

Domestic ₹402.3 Cr (71.8%), exports ₹158.1 Cr (28.2%); both segments growing; tariff headwinds eased

Supported

Order book ₹731 Cr is firm with minimal cancellation risk

Only firm orders in book; cancellations rare even in worst-case tariff scenarios; order quality high

Supported

HTLS ₹200 Cr order book will drive margin accretion

₹200 Cr order book confirmed; Q2 revenue impact zero; longer EPC cycles; execution unproven

Partial (credible intent, execution pending)

Narmadapuram ₹500 Cr FY28 target is on track

Foundation & civil works underway; partial Q1 FY28 commissioning confirmed; timeline unchanged; market absorption unproven

Partial (timeline credible, revenue risk high)

What changed on this call

  • Margin trajectory reaffirmed (6.6% → 7.3% → 8% by Q4)

  • Narmadapuram timeline unchanged: partial Q1 FY28 commissioning, ₹500 Cr FY28, ₹1,200 Cr FY29

  • Export guidance capped at ~30% of revenue; diversifying to Asia, Europe, Oceania

  • HTLS order book announced (₹200 Cr); data center cable approvals in progress

  • 5-year revenue target (₹5,000 Cr by FY31) reaffirmed, not accelerated to 3 years

Bull and bear cases

The ledger
  • Margin recovery on track: 6.6% → 7.3% → 8% trajectory is credible and supported by tariff normalization + metal pricing tailwinds

  • Order book strong at ₹731 Cr (3–4 month execution horizon); no major cancellations even in tariff crisis

  • Narmadapuram greenfield on schedule; doubling capacity to ~60,000 MT by FY29 addresses long-term growth

  • HTLS order book (₹200 Cr) targets ₹50,000+ Cr reconduct market; high-margin opportunity if execution proves out

  • DII accumulation (FII flat) and increasing volume suggest smart money building before Narmadapuram ramp

  • HTLS is nascent: zero Q2 revenue despite ₹200 Cr order book; longer EPC cycles and 220 kV approvals (1–1.5 years) create execution risk

  • Export guidance (₹700–800 Cr FY27) looks tight: H1 run-rate (₹313 Cr) annualizes to ~₹626 Cr, 11% below midpoint

  • Narmadapuram FY28 target (₹500 Cr) dependent on market absorption and product mix; approval timelines uncertain

Risks, ranked by holder concern

What could derail the thesis, and how much it should worry you

HTLS execution unproven: nascent product with longer EPC cycles; ₹200 Cr order book but zero Q2 revenue

Medium

HTLS is critical to Narmadapuram's margin accretion story. If execution slips or customer demand softens, the ₹500 Cr FY28 target becomes at risk.

Export guidance tightness: H1 run-rate (₹313 Cr) annualizes to ~₹626 Cr vs ₹700–800 Cr guidance

Medium

Implies either slower H2 export ramp-up or lower FY27 total revenue. Management capped exports at 30% to reduce US concentration risk, which is prudent but limits upside.

Narmadapuram ramp execution: ₹500 Cr FY28 dependent on market absorption and product mix

Medium

220 kV approvals take 1–1.5 years; plant can start with 11/33/66 kV. If demand softens or approvals delay, the revenue ramp flattens.

US tariff re-escalation: exports at 28% of Q2 revenue; recent normalization (Feb 2026) could reverse

Medium

Recent IEPA court ruling stabilized the tariff environment, but geopolitical risk remains. A re-escalation would hit export margins and delay diversification efforts.

Metal price volatility: copper and aluminum are >75% of metal cost

Low

Company hedges via 3–4 month firm-order policy; most customer orders carry tariff clauses. Mitigated but not eliminated.

The debate

What to watch next
  • 1 · Q3 FY27 margin progression

    The glide-path target is 8% by Q4. Q3 needs to show continued momentum. If margin contracts, the entire guidance narrative breaks.

  • 2 · HTLS revenue visibility

    Any HTLS revenue in Q3 or Q4 FY27 will validate the order book and executive confidence. Zero revenue through FY27 end would be a red flag for execution.

  • 3 · Narmadapuram commissioning timeline

    Foundation and civil work are on track. Partial Q1 FY28 commissioning is the next key milestone. Any slippage here derails the ₹500 Cr FY28 target.

Paramount is a steady-execution story, not a surprise-to-the-upside one. The margin recovery is credible, the order book is strong, and the long-term vision (Narmadapuram + HTLS + data center cables) is ambitious. But execution risks are real: HTLS is unproven, export guidance is tight, and Narmadapuram ramp assumptions are forward-looking. Management knows this, and it's being disciplined — reaffirming guidance despite a 31% revenue pop shows that. The stock has priced in skepticism at a 47% discount from ATH, and DII accumulation suggests smart money is building for the Narmadapuram story. For holders, the next 12–18 months will determine whether the margin glide-path holds and HTLS/Narmadapuram begin to contribute. For new buyers, the window is open — but only if you're willing to take on execution risk and wait. The single number to track from here is Q4 FY27 operating margin: if that clears 8% as guided, the credibility of the entire growth narrative stands.

Informational and educational content only. Not investment advice.